The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting.
The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting. This study will enroll COVID-19 positive patients previously evaluated at Mount Sinai Hospital/Mount Sinai Health System (MSHS) and affiliated hospitals deemed appropriate for home monitoring. Patients will be monitored remotely in the outpatient setting for 1-3 weeks following diagnosis and/or treatment for COVID-19 at MSH/MSHS.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SCREENING
Masking
NONE
This patch provides continuous real-time monitoring of cardiac telemetry, heart rate, respiratory rate and oxygen saturation. Duration of monitoring is typically up to 7 days. This patch is applied to the upper left side of the chest wall, attached with a hypoallergenic adhesive material. (This device is FDA approved for this indication).
Number of different arrhythmias
ac rhythm in patients with COVID-19 infection following treatment/discharge from MSH
Time frame: 7-14 Days
Temperature
Temperature of patients with COVID-19 infection following treatment/discharge from MHS
Time frame: 7-14 Days
Oxygen Saturation
Oxygen saturation level in patients with COVID-19 infection following treatment/discharge from MSH
Time frame: 7-14 Days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.